SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-164621
Filing Date
2021-05-18
Accepted
2021-05-18 08:05:32
Documents
14
Period of Report
2021-05-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d167384d8k.htm   iXBRL 8-K 24759
2 EX-99.1 d167384dex991.htm EX-99.1 7274
6 GRAPHIC g167384img001a.jpg GRAPHIC 4645
  Complete submission text file 0001193125-21-164621.txt   164324

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210518.xsd EX-101.SCH 3103
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210518_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210518_pre.xml EX-101.PRE 11430
7 EXTRACTED XBRL INSTANCE DOCUMENT d167384d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 21933924
SIC: 2834 Pharmaceutical Preparations